Tropic Biosciences
PrivateLast Round
Series C
Extension
Mar 12, 2026
Est. Valuation
$875M
Total Funding Raised
$179.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tropic Biosciences is an agricultural biotechnology company that develops high-performing commercial varieties of tropical crops like bananas, coffee, and rice using gene-editing technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Supply Chain
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tropic Biosciences Comparables
Compare Tropic Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pairwise | 79% | |
| Ohalo Genetics | 76% | |
| Cibus, Inc. | 74% |
Tropic Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Mar 12, 2026 | ||||
| Series C | Jul 6, 2022 | ||||
| Series B | Jun 3, 2020 | ||||
| Series A | Jun 13, 2018 |
Tropic Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agronomics Limited | Series B |
| Just Climate | Series C Extension |
| DisruptAD | Series C |
| Temasek | Series C Extension, Series B |
| Bits x Bites | Series B, Series A |
| Future Planet Capital Regional | Series B |
| Forbion | Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 47% MoM, reaching 8.5K.
- Mar 12, 2026
$105M round completed.
Recent news
Latest coverage and updates
- acquiresJun 23, 2026
Tropic acquired Rahan for $20M on Jun 24th '26.
- is_developingJun 22, 2026
Tropic is developing improved banana varieties that retain the agronomic performance and consumer qualities of.
Tropic Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tropic Biosciences's valuation, stock price, and market status.
Is Tropic Biosciences a public or private company?
Tropic Biosciences is a private company.
What is the current stock price of Tropic Biosciences?
Tropic Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Tropic Biosciences worth (valuation)?
Tropic Biosciences's valuation is estimated at $875.0M based on funding round data.
Can I buy Tropic Biosciences stock?
Tropic Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tropic Biosciences's last funding round?
Tropic Biosciences's most recent funding round was Series C on March 12, 2026.
Who are the main investors in Tropic Biosciences?
Key investors in Tropic Biosciences include DisruptAD, Forbion, Blue Horizon Corporation, Aliment Capital, Five Seasons Ventures.
Will Tropic Biosciences IPO soon?
No public IPO plans have been announced for Tropic Biosciences.
How can I track Tropic Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tropic Biosciences's secondary market activity and sign up for updates.